Contact Us
About Us

Home
Biography
MedBound Hub
Internship
Daily Pulse
Medicine
Physical Therapy
Interview
Pharmacy
Biotechnology
College/Institute
Dentistry
Blog
Wellness & Nutrition
Nursing
Opinion

Home
Biography
MedBound Hub
Internship
Daily Pulse
Medicine
Physical Therapy
Interview
Pharmacy
Biotechnology
College/Institute
Dentistry
Blog
Wellness & Nutrition
Nursing
Opinion

DESTINY-Breast02 trial

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

13 May 2023

2 min read

@Medbound